Hepatitis B Vaccine for Non-responders

PHASE2CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

January 9, 2019

Study Completion Date

January 9, 2019

Conditions
Hepatitis B
Interventions
BIOLOGICAL

HBVaxPro

Three doses of HBVaxPro-10μg at 0, 1, and 2 months. The HBVaxPro-10μg vaccines are administered strictly intramuscularly in the deltoid muscle and must not be injected intravascularly.

BIOLOGICAL

HBAI20

Three doses of HBAI20 at 0, 1, and 2 months. The HBAI20 vaccines are administered strictly intramuscularly in the deltoid muscle and must not be injected intravascularly.

Trial Locations (3)

Unknown

Vaxinfectio - Antwerp University, Antwerp

Ziekenhuis Oost-Limburg, Genk

6202 AZ

Maastricht UMC, Maastricht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CyTuVax

OTHER

lead

Maastricht University Medical Center

OTHER